Skip to main content
. 2020 Jun 10;12(6):534. doi: 10.3390/pharmaceutics12060534

Table 4.

Statistical analysis of variance (ANOVA) of the responses (Y1 and Y2) results.

Factors Disintegration Time (Y1), min Cumulative Release after 60 min (Y2), %
Estimate F-Ratio p-Value Estimate F-Ratio p-Value
X1 −190.0 2166.00 0.0001 * 35.83 311.63 0.0001 *
X2 35.0 73.50 0.0004 * −3.58 3.10 0.1384
X3 65.0 253.50 0.0001 * −8.5 17.54 0.0086 *
X1X1 50.83 71.56 0.0004 * −2.83 0.90 0.3864
X1X2 5.0 0.75 0.4261 −0.9 0.10 0.7665
X1X3 −55.0 90.75 0.0002 * 0.05 0.00 0.9868
X2X2 10.83 3.25 0.1313 −2.83 0.90 0.3864
X2X3 15.0 6.75 0.0484 * −1.35 0.22 0.6579
X3X3 10.83 3.25 0.1313 9.72 10.58 0.0226 *
R2 99.81 98.58
Adj. R2 99.48 96.01
SEE 5.77 2.87
MAE 2.44 1.23

Note: * Significant effect of factors on individual responses. Abbreviations: X1, croscarmellose sodium percentage; X2, gelatin solution concentration; X3, Hydroxypropyl methylcellulose percentage; X1X2, X1X3, X2X3, the interaction term between the factors; X1X1, X2X2, and X3X3, the quadratic terms between the factors; R2, R-squared; Adj-R2, adjusted R-squared; SEE, standard error of estimate; MAE, mean absolute error.